speb/financial-data huggingface dataset:
CRN.L cash_flow (annual, 2025-12-31) — Issuance Of Debt: 491521000.00
CRN.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4203000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4203000.00
CRN.L balance_sheet (annual, 2025-12-31) — Long Term Debt: 183957000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 183957000.00
CRN.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 188160000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 188160000.00
CRN.L cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 491521000.00
CRN.L cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -447706000.00
CRN.L balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 34000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 34000.00
CRN.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 11937000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 11937000.00
CRN.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -7828000.00
CRN.L balance_sheet (annual, 2025-12-31) — Net Debt: 171303000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Net Debt: 171303000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income: 132715000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 132715000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 132715000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 132715000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 132715000.00
CRN.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 132715000.00
CRN.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 132715000.00
CRN.L cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -1402000.00
CRN.L income_statement (annual, 2025-12-31) — Net Interest Income: -16037000.00
CRN.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 43815000.00
CRN.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 43815000.00
CRN.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -16037000.00
CRN.L balance_sheet (annual, 2025-12-31) — Net PPE: 11464000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 11464000.00
CRN.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1448000.00
CRN.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 832213000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 832213000.00
CRN.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2715000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2715000.00
CRN.L income_statement (annual, 2025-12-31) — Normalized EBITDA: 170568000.00
CRN.L income_statement (annual, 2025-12-31) — Normalized Income: 132822965.62
CRN.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: 70622000.00
CRN.L income_statement (annual, 2025-12-31) — Operating Income: 168586000.00
CRN.L income_statement (annual, 2025-12-31) — Operating Revenue: 944606000.00
CRN.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 617728891.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 617728891.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 49538000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 49538000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Equity Interest: 15004000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 15004000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4455000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4455000.00
CRN.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 16037000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 28306000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 28306000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Payable: 1708000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 1708000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Properties: 8479000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Properties: 8479000.00
CRN.L balance_sheet (annual, 2025-12-31) — Other Receivables: 88370000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 88370000.00
CRN.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRN.L balance_sheet (annual, 2025-12-31) — Payables: 67579000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Payables: 67579000.00
CRN.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1604000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1604000.00
CRN.L income_statement (annual, 2025-12-31) — Pretax Income: 152425000.00
CRN.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRN.L cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -1402000.00
CRN.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1448000.00
CRN.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 735841000.00
CRN.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2633000.00
CRN.L cash_flow (annual, 2025-12-31) — Repayment Of Debt: -447706000.00
CRN.L cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -7833000.00
CRN.L balance_sheet (annual, 2025-12-31) — Retained Earnings: 633352000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 633352000.00
CRN.L income_statement (annual, 2025-12-31) — Selling General And Administration: 12264000.00
CRN.L balance_sheet (annual, 2025-12-31) — Share Issued: 625576122.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 625576122.00
CRN.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 5986000.00
CRN.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 836668000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 836668000.00
CRN.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 832213000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 832213000.00
CRN.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -16034.38
CRN.L income_statement (annual, 2025-12-31) — Tax Provision: 19710000.00
CRN.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.13
CRN.L balance_sheet (annual, 2025-12-31) — Taxes Receivable: 0.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 0.00
CRN.L cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -20009000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Assets: 1306184000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 1306184000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 1020625000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1020625000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Debt: 231955000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 231955000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 836668000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 836668000.00
CRN.L income_statement (annual, 2025-12-31) — Total Expenses: 776020000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 469516000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 469516000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 24172000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 24172000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 219186000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 219186000.00
CRN.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 168586000.00
CRN.L income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1197000.00
CRN.L balance_sheet (annual, 2025-12-31) — Total Tax Payable: 22972000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 22972000.00
CRN.L income_statement (annual, 2025-12-31) — Total Unusual Items: -124000.00
CRN.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -124000.00
CRN.L balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 7847231.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7847231.00
CRN.L balance_sheet (annual, 2025-12-31) — Treasury Stock: 14202000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 14202000.00
CRN.L balance_sheet (annual, 2025-12-31) — Work In Process: 413821000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Work In Process: 413821000.00
CRN.L balance_sheet (annual, 2025-12-31) — Working Capital: 1031682000.00
CRN.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 1031682000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Accounts Receivable: 0.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 0.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 4678000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 2724000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Common Stock Issuance: 175200000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 1349000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 175200000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 1375000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Long Term Debt: 49523000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 50898000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
CRNA.OL cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -2023000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 175200000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
CRNA.OL cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
CRNA.OL cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -1000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 59314000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Other Current Assets: -1000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 371727000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: -1000.00
CRNA.OL balance_sheet (annual, 2021-12-31) — Properties: 0.00
CRNA.OL cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
CRNA.OL cash_flow (annual, 2021-12-31) — Repayment Of Debt: -2023000.00
CRNA.OL cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -2023000.00
CRNA.OL income_statement (annual, 2022-12-31) — +Operating Expense: 503593000.00
CRNA.OL income_statement (annual, 2022-12-31) — +Total Revenue: 10002000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 11383000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 6250000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5490000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 0.00
CRNA.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 6486766.00
CRNA.OL income_statement (annual, 2022-12-31) — Basic EPS: -66.81
CRNA.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 181682000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4678000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -4959000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1455000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 18847000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 62967000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 62967000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Cash Equivalents: 62967000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 6517000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Change In Receivables: -18890000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: -12373000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Changes In Cash: -118128000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Common Stock: 18847000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2566000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Common Stock Issuance: 20000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Current Assets: 94112000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1455000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Current Debt: 4531000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5986000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 40415000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Depreciation: 392673000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 392673000.00
CRNA.OL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 392673000.00
CRNA.OL income_statement (annual, 2022-12-31) — Depreciation Income Statement: 392673000.00
CRNA.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 6486766.00
CRNA.OL income_statement (annual, 2022-12-31) — Diluted EPS: -66.81
CRNA.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -432898000.00
CRNA.OL income_statement (annual, 2022-12-31) — EBIT: -490334000.00
CRNA.OL income_statement (annual, 2022-12-31) — EBITDA: -97661000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 2462000.00
CRNA.OL cash_flow (annual, 2022-12-31) — End Cash Position: 66015000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4328000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: -113800000.00
CRNA.OL income_statement (annual, 2022-12-31) — General And Administrative Expense: 5020000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 21000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 11770000.00
CRNA.OL income_statement (annual, 2022-12-31) — Interest Expense: 4994000.00
CRNA.OL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4994000.00
CRNA.OL income_statement (annual, 2022-12-31) — Interest Income: 536000.00
CRNA.OL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 536000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Interest Paid Cff: -680000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Interest Received Cfo: 536000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 64530000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -4959000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 20000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Long Term Debt: 57433000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 57433000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2086000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 7092000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 20000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -2823000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income: -432898000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -432898000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -432898000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -432898000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -432898000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -495328000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -432898000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -24000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Interest Income: -4561000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2086000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2086000.00
CRNA.OL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -4561000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Net PPE: 6280000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4935000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -2086000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2545000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CRNA.OL income_statement (annual, 2022-12-31) — Normalized EBITDA: -97661000.00
CRNA.OL income_statement (annual, 2022-12-31) — Normalized Income: -432898000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Operating Cash Flow: -108841000.00
CRNA.OL income_statement (annual, 2022-12-31) — Operating Income: -493591000.00
CRNA.OL income_statement (annual, 2022-12-31) — Operating Revenue: 10002000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 6573339.00
CRNA.OL cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Other Current Assets: -1000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 19972000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 21000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4314000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1000.00
CRNA.OL income_statement (annual, 2022-12-31) — Other Operating Expenses: 6469000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Other Receivables: 20632000.00
CRNA.OL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Payables: 11383000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1216000.00
CRNA.OL income_statement (annual, 2022-12-31) — Pretax Income: -495328000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRNA.OL cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -24000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4935000.00
CRNA.OL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 392673000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2086000.00
CRNA.OL income_statement (annual, 2022-12-31) — Research And Development: 47228000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Restricted Cash: 3048000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Retained Earnings: -123672000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CRNA.OL income_statement (annual, 2022-12-31) — Selling General And Administration: 5020000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Share Issued: 6573339.00
CRNA.OL cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CRNA.OL cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -2086000.00
CRNA.OL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4160000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2566000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2545000.00
CRNA.OL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CRNA.OL income_statement (annual, 2022-12-31) — Tax Provision: -62430000.00
CRNA.OL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.13
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Assets: 100414000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Capitalization: 59999000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Debt: 63419000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2566000.00
CRNA.OL income_statement (annual, 2022-12-31) — Total Expenses: 503593000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 97848000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6302000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 57433000.00
CRNA.OL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -493591000.00
CRNA.OL income_statement (annual, 2022-12-31) — Total Other Finance Cost: 103000.00
CRNA.OL balance_sheet (annual, 2022-12-31) — Working Capital: 53697000.00
CRNA.OL income_statement (annual, 2023-12-31) — +Operating Expense: 100088000.00
CRNA.OL income_statement (annual, 2023-12-31) — +Total Revenue: 123000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Accounts Payable: 3450000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 108000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2518000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Basic Average Shares: 7005137.00
CRNA.OL income_statement (annual, 2023-12-31) — Basic EPS: -16.12
CRNA.OL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 66015000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4678000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Capital Expenditure: -193000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Capital Stock: 4484000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 21900000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 21900000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Cash Equivalents: 21900000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -20984000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Change In Receivables: 28225000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Change In Working Capital: 7241000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Changes In Cash: -44320000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Common Stock: 4484000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Common Stock Equity: -98542000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Common Stock Issuance: 10000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Current Assets: 25698000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Current Debt: 110434000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 110434000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Current Liabilities: 124253000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Depreciation: 1773000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1773000.00
CRNA.OL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1773000.00
CRNA.OL income_statement (annual, 2023-12-31) — Depreciation Income Statement: 1773000.00
CRNA.OL income_statement (annual, 2023-12-31) — Diluted Average Shares: 7005137.00
CRNA.OL income_statement (annual, 2023-12-31) — Diluted EPS: -16.12
CRNA.OL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — EBIT: -109384000.00
CRNA.OL income_statement (annual, 2023-12-31) — EBITDA: -107611000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 555000.00
CRNA.OL cash_flow (annual, 2023-12-31) — End Cash Position: 22250000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Financing Cash Flow: 41929000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Free Cash Flow: -89389000.00
CRNA.OL income_statement (annual, 2023-12-31) — General And Administrative Expense: 4834000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 13000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Gross PPE: 2518000.00
CRNA.OL income_statement (annual, 2023-12-31) — Interest Expense: 3557000.00
CRNA.OL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3557000.00
CRNA.OL income_statement (annual, 2023-12-31) — Interest Income: 658000.00
CRNA.OL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 658000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Interest Paid Cff: -244000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Interest Received Cfo: 658000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Invested Capital: 11892000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Investing Cash Flow: 2947000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 10000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 59000000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Long Term Debt: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CRNA.OL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2712000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2518000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 10000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Net Debt: 88534000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -884000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -112941000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -112941000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -112941000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Interest Income: -13859000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 56288000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -2712000.00
CRNA.OL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -13859000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 1000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Net PPE: 0.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 2947000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 56288000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -98555000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Normalized EBITDA: -107611000.00
CRNA.OL income_statement (annual, 2023-12-31) — Normalized Income: -112941000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Operating Cash Flow: -89196000.00
CRNA.OL income_statement (annual, 2023-12-31) — Operating Income: -99965000.00
CRNA.OL income_statement (annual, 2023-12-31) — Operating Revenue: 123000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 7819851.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 8696000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 13000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 13433000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -291000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1000.00
CRNA.OL income_statement (annual, 2023-12-31) — Other Operating Expenses: 9149000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Other Receivables: 3448000.00
CRNA.OL income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Payables: 3450000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Pretax Income: -112941000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRNA.OL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
CRNA.OL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -193000.00
CRNA.OL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1773000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2712000.00
CRNA.OL income_statement (annual, 2023-12-31) — Research And Development: 49890000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Restricted Cash: 350000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Retained Earnings: -142453000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Sale Of PPE: 3140000.00
CRNA.OL income_statement (annual, 2023-12-31) — Selling General And Administration: 4834000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Share Issued: 7819851.00
CRNA.OL cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 59000000.00
CRNA.OL cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2712000.00
CRNA.OL income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CRNA.OL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1523000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Stockholders Equity: -98542000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Tangible Book Value: -98555000.00
CRNA.OL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Tax Provision: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Assets: 25712000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Capitalization: -98542000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Debt: 110434000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -98542000.00
CRNA.OL income_statement (annual, 2023-12-31) — Total Expenses: 100088000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 124254000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 13000.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CRNA.OL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -99965000.00
CRNA.OL income_statement (annual, 2023-12-31) — Total Other Finance Cost: 10960000.00
CRNA.OL income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CRNA.OL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CRNA.OL balance_sheet (annual, 2023-12-31) — Working Capital: -98555000.00
CRNA.OL income_statement (annual, 2023-12-31) — Write Off: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — +Operating Expense: 42495000.00
CRNA.OL income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Accounts Payable: 4713000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 4713000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5000.00
CRNA.OL income_statement (annual, 2024-12-31) — Basic Average Shares: 21315942.00
CRNA.OL income_statement (annual, 2024-12-31) — Basic EPS: 2.70
CRNA.OL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 22250000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Capital Expenditure: -189000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Capital Stock: 42090000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Capital Stock: 42090000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 18213000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 18213000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 18213000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 18213000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Cash Equivalents: 18213000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 18213000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 3802000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Change In Receivables: -1605000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Change In Working Capital: 2197000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Changes In Cash: -4086000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Common Stock: 42090000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Common Stock: 42090000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Common Stock Equity: -12510000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -12510000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Current Assets: 21639000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Current Assets: 21639000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Current Debt: 17356000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Current Debt: 17356000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 17356000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 17356000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Current Liabilities: 34339000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 34339000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Depreciation: -1103000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: -1103000.00
CRNA.OL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 13000.00
CRNA.OL income_statement (annual, 2024-12-31) — Depreciation Income Statement: 13000.00
CRNA.OL income_statement (annual, 2024-12-31) — Diluted Average Shares: 21315942.00
CRNA.OL income_statement (annual, 2024-12-31) — Diluted EPS: 2.70
CRNA.OL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — EBIT: 57543000.00
CRNA.OL income_statement (annual, 2024-12-31) — EBITDA: 57556000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 92000.00
CRNA.OL cash_flow (annual, 2024-12-31) — End Cash Position: 18255000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Financing Cash Flow: 36635000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Free Cash Flow: -40721000.00
CRNA.OL income_statement (annual, 2024-12-31) — General And Administrative Expense: 3784000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 5000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Gross PPE: 189000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Gross PPE: 189000.00
CRNA.OL income_statement (annual, 2024-12-31) — Interest Expense: 20000.00
CRNA.OL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 20000.00
CRNA.OL income_statement (annual, 2024-12-31) — Interest Income: 61000.00
CRNA.OL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 61000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Interest Paid Cff: 0.00
CRNA.OL cash_flow (annual, 2024-12-31) — Interest Received Cfo: 62000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Invested Capital: 4846000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Invested Capital: 4846000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -189000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
CRNA.OL cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRNA.OL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 13500000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 189000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 189000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 57523000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 57523000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Interest Income: 101143000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 13500000.00
CRNA.OL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 101143000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Net PPE: 184000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Net PPE: 184000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -189000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 13500000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -12515000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -12515000.00
CRNA.OL income_statement (annual, 2024-12-31) — Normalized EBITDA: 58672000.00
CRNA.OL income_statement (annual, 2024-12-31) — Normalized Income: 58639000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Operating Cash Flow: -40532000.00
CRNA.OL income_statement (annual, 2024-12-31) — Operating Income: -42495000.00
CRNA.OL income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 72448036.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 72448036.00
CRNA.OL cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 10806000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 10806000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Other Non Cash Items: -100159000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 1000.00
CRNA.OL income_statement (annual, 2024-12-31) — Other Operating Expenses: 4870000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Other Receivables: 3311000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3311000.00
CRNA.OL income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Payables: 4713000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Payables: 4713000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Prepaid Assets: 73000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 73000.00
CRNA.OL income_statement (annual, 2024-12-31) — Pretax Income: 57523000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -189000.00
CRNA.OL income_statement (annual, 2024-12-31) — Reconciled Depreciation: -1103000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Research And Development: 11688000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Restricted Cash: 42000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 42000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Retained Earnings: -54548000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -54548000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Selling General And Administration: 3784000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Share Issued: 72448036.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Share Issued: 72448036.00
CRNA.OL cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 13500000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Special Income Charges: -1116000.00
CRNA.OL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 950000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Stockholders Equity: -12510000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -12510000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Tangible Book Value: -12515000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -12515000.00
CRNA.OL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CRNA.OL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Assets: 21830000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Assets: 21830000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Capitalization: -12510000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -12510000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Debt: 17356000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Debt: 17356000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -12510000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -12510000.00
CRNA.OL income_statement (annual, 2024-12-31) — Total Expenses: 42495000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 34340000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 34340000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 190000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 190000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1000.00
CRNA.OL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -42493000.00
CRNA.OL income_statement (annual, 2024-12-31) — Total Other Finance Cost: -101102000.00
CRNA.OL income_statement (annual, 2024-12-31) — Total Unusual Items: -1116000.00
CRNA.OL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1116000.00
CRNA.OL balance_sheet (annual, 2024-12-31) — Working Capital: -12700000.00
CRNA.OL balance_sheet (quarterly, 2024-12-31) — Working Capital: -12700000.00
CRNA.OL income_statement (annual, 2024-12-31) — Write Off: 1116000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5606000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6220000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 743000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 63305000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6346000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6346000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Common Stock: 63305000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -12402000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Current Assets: 12567000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Current Debt: 11111000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11111000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 25150000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Invested Capital: -1291000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Net Debt: 4765000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Net PPE: 181000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -12403000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 108963721.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 7505000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Payables: 5606000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -76986000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Share Issued: 108963721.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -12402000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -12403000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Assets: 12749000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -12402000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Debt: 11111000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -12402000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 25151000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 182000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1000.00
CRNA.OL balance_sheet (quarterly, 2025-06-30) — Working Capital: -12583000.00
CRNA.OL income_statement (annual, 2025-12-31) — +Operating Expense: 41051000.00
CRNA.OL income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Accounts Payable: 3051000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3051000.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 0.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 0.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -24000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -24000.00
CRNA.OL income_statement (annual, 2025-12-31) — Basic Average Shares: 107905761.00
CRNA.OL income_statement (annual, 2025-12-31) — Basic EPS: -0.43
CRNA.OL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 18255000.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Capital Stock: 86175000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 86175000.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 6044000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 6044000.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6044000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6044000.00
CRNA.OL balance_sheet (annual, 2025-12-31) — Cash Equivalents: 6044000.00
CRNA.OL balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 6044000.00